Skip to main content
. 2020 Oct 19;22(6):5348–5357. doi: 10.3892/mmr.2020.11614

Figure 9.

Figure 9.

SB203580 inhibits the activation of p-p38 MAPK, regulates A1R and ENT1, and decreases the number of seizures and brain tissue damage. Dashed arrows represent suppression. p-, phosphorylated; A1R, adenosine A1 receptor; ENT1, type 1 equilibrative nucleoside transporter.